Beta2-agonist administration increases sarcoplasmic reticulum Ca2+-ATPase activity in aged rat skeletal muscle.
about
Treatment with a corticotrophin releasing factor 2 receptor agonist modulates skeletal muscle mass and force production in aged and chronically ill animalsMotor unit changes seen with skeletal muscle sarcopenia in oldest old rats.Reduction of AMP-activated protein kinase alpha2 increases endoplasmic reticulum stress and atherosclerosis in vivo.Prevention of muscle aging by myofiber-associated satellite cell transplantation.Modulation of insulin-like growth factor (IGF)-I and IGF-binding protein interactions enhances skeletal muscle regeneration and ameliorates the dystrophic pathology in mdx mice.Parvalbumin gene transfer impairs skeletal muscle contractility in old miceRole of beta-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and disease.Suppressed sympathetic outflow to skeletal muscle, muscle thermogenesis, and activity energy expenditure with calorie restriction.Polyunsaturated fatty acids mobilize intracellular Ca2+ in NT2 human teratocarcinoma cells by causing release of Ca2+ from mitochondria.Initiating treadmill training in late middle age offers modest adaptations in Ca2+ handling but enhances oxidative damage in senescent rat skeletal muscle.Comparative evaluation of IGF-I gene transfer and IGF-I protein administration for enhancing skeletal muscle regeneration after injury.Insulin-like growth factor-I analogue protects muscles of dystrophic mdx mice from contraction-mediated damage.Intramuscular beta2-agonist administration enhances early regeneration and functional repair in rat skeletal muscle after myotoxic injury.Microbiological and physicochemical properties of red claw crayfish (Cherax quadricarinatus) stored in different package systems at 2 degrees C.The NLRP3 inflammasome contributes to sarcopenia and lower muscle glycolytic potential in old mice.Age-related functional changes and susceptibility to eccentric contraction-induced damage in skeletal muscle cell.Oxidative stress-induced dysregulation of excitation-contraction coupling contributes to muscle weakness
P2860
Q28570699-CEB22630-B82D-4E98-820B-DFF4FDF62F88Q33615986-5D84DCC9-A0A5-438A-9C98-007BE27D3CDDQ33675689-3DD02D9E-31BB-400D-950D-4F82129E6332Q35627456-14BD0033-9071-449D-A45B-1E077C920547Q36007403-33F6BF98-C1CC-46D9-8EBF-0B3EB0BB91E4Q36147528-A0348901-4AE5-449C-B1F3-7583500F8C81Q37129351-F740197E-500D-4026-B1A1-1DBB4F9136FDQ38938629-5B422606-4A24-477F-AE13-081E46AE7082Q40294764-BB9DC588-E30E-4D03-889D-97992006DFDFQ43143812-DBCA6E65-3F8B-4143-8F84-0AF2AF9698E0Q45861368-E0521D62-5D56-4AC9-B224-295808D35DADQ46528995-B453F7C5-481B-4907-B37B-839A130F7093Q46626845-45D21DC6-61CC-4188-9D00-20FD5A619748Q50670692-16C71E56-167E-4452-BAB0-53D559240174Q50985315-86EFD8AD-F2CF-48D9-B216-D5538324A0B4Q51825383-EFBCD7A9-7F18-47B4-9AB2-A68244237D1AQ58802583-B9102FB7-2DB3-4781-BE79-701F6223CC53
P2860
Beta2-agonist administration increases sarcoplasmic reticulum Ca2+-ATPase activity in aged rat skeletal muscle.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Beta2-agonist administration i ...... y in aged rat skeletal muscle.
@en
Beta2-agonist administration i ...... y in aged rat skeletal muscle.
@nl
type
label
Beta2-agonist administration i ...... y in aged rat skeletal muscle.
@en
Beta2-agonist administration i ...... y in aged rat skeletal muscle.
@nl
prefLabel
Beta2-agonist administration i ...... y in aged rat skeletal muscle.
@en
Beta2-agonist administration i ...... y in aged rat skeletal muscle.
@nl
P2093
P2860
P50
P1476
Beta2-agonist administration i ...... ty in aged rat skeletal muscle
@en
P2093
David R Plant
Felice Beitzel
Jonathan D Schertzer
P2860
P304
P356
10.1152/AJPENDO.00399.2004
P577
2004-10-12T00:00:00Z